Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 30 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer				Phase II, Phase I				OHSU-HEM-05011-L OHSU-210, NCT00245037
	Study of Pralatrexate and Gemcitabine With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Lymphoproliferative Malignancies				Phase II, Phase I				PDX-009 NCT00481871
	Phase I, Open-Label, Dose-Escalation, Safety and Pharmacokinetics (PK) Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)				Phase II, Phase I				D2782C00007 NCT00486265
	Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disease				Phase II, Phase I				BCM-H-19386 BCM-FAB, H 19386, NCT00625144
	A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies				Phase II, Phase I				CLBH589B2102 NCT00621244
	Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies				Phase II, Phase I				8717 NCT00673114
	Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer				Phase II				NHLBI-99-H-0050 NCT00003838
	Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers				Phase II				SGL2003 NCT00421213
	A Phase II Study of Umbilical Cord Blood Transplantation				Phase II				UCBT001 NCT00676806
	T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies				Phase II				11300A NCT00683046


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute